Prognostic Nutritional Index Predicts Outcomes in Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab: A Propensity Score-matched Analysis
PNI is an independent prognostic factor for overall survival in advanced HCC patients treated with Ate/Bev in real-world clinical practice. Incorporating PNI into routine assessments may enhance risk stratification and guide therapeutic decision-making.
Authors
- Chao‐Hung Hung (ORCID: https://orcid.org/0000-0003-1646-9519)
- Yen‐Hao Chen (ORCID: https://orcid.org/0000-0002-5622-5490)
- Yuan‐Hung Kuo (ORCID: https://orcid.org/0000-0003-0185-1846)
- Chen‐Chun Lin (ORCID: https://orcid.org/0000-0002-2907-2679)
- Jing‐Houng Wang (ORCID: https://orcid.org/0000-0002-4916-9814)
- Po‐Ting Lin (ORCID: https://orcid.org/0000-0002-7486-8908)
- Wei Teng (ORCID: https://orcid.org/0000-0001-5663-1440)
- Chun‐Yen Lin (ORCID: https://orcid.org/0000-0003-3007-3190)
- Wei‐Ting Chen (ORCID: https://orcid.org/0000-0001-8246-0219)
- Tsung‐Han Wu (ORCID: https://orcid.org/0000-0001-8455-8009)
- Chung‐Wei Su (ORCID: https://orcid.org/0000-0003-2778-3618)
- Shi‐Ming Lin (ORCID: https://orcid.org/0000-0001-7527-6181)
- Sheng‐Nan Lu
Institutions
- Chang Gung University (TW)
- Chang Gung Memorial Hospital (TW)
- Taipei Municipal YangMing Hospital (TW)
- Kaohsiung Chang Gung Memorial Hospital (TW)
- Linkou Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- Journal of Clinical and Translational Hepatology
- Published
- 2025-12-08
- DOI
- https://doi.org/10.14218/jcth.2025.00418
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chang Gung Medical Foundation
- Kaohsiung Chang Gung Memorial Hospital